SYNCRIP Facilitates Porcine Parvovirus Viral DNA Replication
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Molecular Analysis of Carnivore Protoparvovirus Detected in White Blood Cells of Naturally Infected Cats
Balboni et al. BMC Veterinary Research (2018) 14:41 DOI 10.1186/s12917-018-1356-9 RESEARCHARTICLE Open Access Molecular analysis of carnivore Protoparvovirus detected in white blood cells of naturally infected cats Andrea Balboni1, Francesca Bassi1, Stefano De Arcangeli1, Rosanna Zobba2, Carla Dedola2, Alberto Alberti2 and Mara Battilani1* Abstract Background: Cats are susceptible to feline panleukopenia virus (FPV) and canine parvovirus (CPV) variants 2a, 2b and 2c. Detection of FPV and CPV variants in apparently healthy cats and their persistence in white blood cells (WBC) and other tissues when neutralising antibodies are simultaneously present, suggest that parvovirus may persist long-term in the tissues of cats post-infection without causing clinical signs. The aim of this study was to screen a population of 54 cats from Sardinia (Italy) for the presence of both FPV and CPV DNA within buffy coat samples using polymerase chain reaction (PCR). The DNA viral load, genetic diversity, phylogeny and antibody titres against parvoviruses were investigated in the positive cats. Results: Carnivore protoparvovirus 1 DNA was detected in nine cats (16.7%). Viral DNA was reassembled to FPV in four cats and to CPV (CPV-2b and 2c) in four cats; one subject showed an unusually high genetic complexity with mixed infection involving FPV and CPV-2c. Antibodies against parvovirus were detected in all subjects which tested positive to DNA parvoviruses. Conclusions: The identification of FPV and CPV DNA in the WBC of asymptomatic cats, despite the presence of specific antibodies against parvoviruses, and the high genetic heterogeneity detected in one sample, confirmed the relevant epidemiological role of cats in parvovirus infection. -
A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated. -
Porcine Parvovirus VP1/VP2 on a Time Series Epitope Mapping: Exploring the Effects of High Hydrostatic Pressure on the Immune Recognition of Antigens
bioRxiv preprint doi: https://doi.org/10.1101/330589; this version posted May 25, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Porcine Parvovirus VP1/VP2 on a Time Series Epitope Mapping: exploring the effects of high hydrostatic pressure on the immune recognition of antigens. Ancelmo Rabelo de Souzaa, Marriam Yamina, Danielle Gavac, Janice Reis Ciacci Zanellac, Maria Sílvia Viccari Gattia, Carlos Francisco Sampaio Bonafea, Daniel Ferreira de Lima Netoa,b* aDepartamento de Bioquímica e Biologia Tecidual e bDepartamento de Genética, Evolução e Bioagentes, Instituto de Biologia, Universidade Estadual de Campinas (UNICAMP), Rua Monteiro Lobato, 255, Cidade Universitária Zeferino Vaz, 13083- 862, Campinas, SP, Brazil. cEmbrapa Suínos e Aves, Laboratório de Virologia de Suínos, 89715-899, Concórdia, SC, Brazil. *Corresponding author: Tel.: +55 19 3521-6229; E-mail: [email protected] bioRxiv preprint doi: https://doi.org/10.1101/330589; this version posted May 25, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. ABSTRACT Porcine parvovirus (PPV) is a DNA virus that causes reproductive failure in gilts and sows, resulting in embryonic and fetal losses worldwide. Epitope mapping of PPV is important for developing new vaccines. In this study, we used spot synthesis analysis for epitope mapping of the capsid proteins of PPV (NADL-2 strain) and correlated the findings with predictive data from immunoinformatics. The virus was exposed to three conditions prior to inoculation in pigs: native (untreated), high hydrostatic pressure (350 MPa for 1 h) at room temperature and high hydrostatic pressure (350 MPa for 1 h) at -18 °C, compared with a commercial vaccine produced using inactivated PPV. -
Protoparvovirus Knocking at the Nuclear Door
viruses Review Protoparvovirus Knocking at the Nuclear Door Elina Mäntylä 1 ID , Michael Kann 2,3,4 and Maija Vihinen-Ranta 1,* 1 Department of Biological and Environmental Science and Nanoscience Center, University of Jyvaskyla, FI-40500 Jyvaskyla, Finland; elina.h.mantyla@jyu.fi 2 Laboratoire de Microbiologie Fondamentale et Pathogénicité, University of Bordeaux, UMR 5234, F-33076 Bordeaux, France; [email protected] 3 Centre national de la recherche scientifique (CNRS), Microbiologie Fondamentale et Pathogénicité, UMR 5234, F-33076 Bordeaux, France 4 Centre Hospitalier Universitaire de Bordeaux, Service de Virologie, F-33076 Bordeaux, France * Correspondence: maija.vihinen-ranta@jyu.fi; Tel.: +358-400-248-118 Received: 5 September 2017; Accepted: 29 September 2017; Published: 2 October 2017 Abstract: Protoparvoviruses target the nucleus due to their dependence on the cellular reproduction machinery during the replication and expression of their single-stranded DNA genome. In recent years, our understanding of the multistep process of the capsid nuclear import has improved, and led to the discovery of unique viral nuclear entry strategies. Preceded by endosomal transport, endosomal escape and microtubule-mediated movement to the vicinity of the nuclear envelope, the protoparvoviruses interact with the nuclear pore complexes. The capsids are transported actively across the nuclear pore complexes using nuclear import receptors. The nuclear import is sometimes accompanied by structural changes in the nuclear envelope, and is completed by intranuclear disassembly of capsids and chromatinization of the viral genome. This review discusses the nuclear import strategies of protoparvoviruses and describes its dynamics comprising active and passive movement, and directed and diffusive motion of capsids in the molecularly crowded environment of the cell. -
Datasheet: VPA00486 Product Details
Datasheet: VPA00486 Description: RABBIT ANTI hnRNPQ / SYNCRIP Specificity: hnRNP Q / SYNCRIP Format: Semi Pure Product Type: PrecisionAb™ Polyclonal Isotype: Polyclonal IgG Quantity: 100 µl Product Details Applications This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit www.bio-rad-antibodies.com/protocols. Yes No Not Determined Suggested Dilution Western Blotting 1/1000 PrecisionAb antibodies have been extensively validated for the western blot application. The antibody has been validated at the suggested dilution. Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Further optimization may be required dependant on sample type. Target Species Human Species Cross Reacts with: Mouse Reactivity N.B. Antibody reactivity and working conditions may vary between species. Product Form Purified IgG - liquid Preparation Rabbit Ig fraction prepared by ammonium sulphate precipitation Buffer Solution Phosphate buffered saline Preservative 0.09% Sodium Azide (NaN ) Stabilisers 3 Immunogen KLH conjugated synthetic peptide corresponding to amino acid 591-623 of human hnRNP Q External Database Links UniProt: O60506 Related reagents Entrez Gene: 10492 SYNCRIP Related reagents Synonyms HNRPQ, NSAP1 Page 1 of 2 Specificity Rabbit anti Human hnRNP Q / SYNCRIP antibody recognizes hnRNP Q / SYNCRIP also known as heterogeneous nuclear ribonucleoprotein Q, NS1-associated protein 1, glycine- and tyrosine-rich RNA-binding protein or Synaptotagmin-binding, cytoplasmic RNA-interacting protein. Encode by the SYNCRIP gene, hnRNP Q is a member of the cellular heterogeneous nuclear ribonucleoprotein (hnRNP) family. -
Posttranscriptional Regulation of HLA-A Protein Expression By
Posttranscriptional Regulation of HLA-A Protein Expression by Alternative Polyadenylation Signals Involving the RNA-Binding Protein Syncrip This information is current as of September 27, 2021. Smita Kulkarni, Veron Ramsuran, Marijana Rucevic, Sukhvinder Singh, Alexandra Lied, Viraj Kulkarni, Colm O'hUigin, Sylvie Le Gall and Mary Carrington J Immunol 2017; 199:3892-3899; Prepublished online 20 October 2017; Downloaded from doi: 10.4049/jimmunol.1700697 http://www.jimmunol.org/content/199/11/3892 http://www.jimmunol.org/ Supplementary http://www.jimmunol.org/content/suppl/2017/10/20/jimmunol.170069 Material 7.DCSupplemental References This article cites 66 articles, 30 of which you can access for free at: http://www.jimmunol.org/content/199/11/3892.full#ref-list-1 Why The JI? Submit online. by guest on September 27, 2021 • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2017 by The American -
And Coinfections with Feline Viral Pathogens in Domestic Cats in Brazil
Ciência Rural,Felis catusSanta gammaherpesvirus Maria, v.48: 03, 1 (FcaGHV1) e20170480, and 2018coinfections with feline viral pathogens http://dx.doi.org/10.1590/0103-8478cr20170480 in domestic cats in Brazil. 1 ISSNe 1678-4596 MICROBIOLOGY Felis catus gammaherpesvirus 1 (FcaGHV1) and coinfections with feline viral pathogens in domestic cats in Brazil Jacqueline Kazue Kurissio1, 2* Marianna Vaz Rodrigues1, 2 Sueli Akemi Taniwaki3 Marcelo de Souza Zanutto4 Claudia Filoni1, 2 Maicon Vinícius Galdino5 João Pessoa Araújo Júnior 1, 2* 1Departamento de Microbiologia e Imunologia, Instituto de Biociências, Faculdade de Medicina Veterinária e Zootecnia (FMVZ), Universidade Estadual Paulista “Júlio de Mesquita Filho” (UNESP), 18618-691, Botucatu, SP, Brasil. 2Instituto de Biotecnologia, Universidade Estadual Paulista “Júlio de Mesquita Filho” (UNESP), Botucatu, SP, Brasil. E-mail: [email protected] 3Departamento de Medicina Veterinária Preventiva e Saúde Animal, Faculdade de Medicina Veterinária e Zootecnia (FMVZ), Universidade de São Paulo (USP), SP, Brasil. 4Departamento de Clínicas Veterinárias, Centro de Ciências Agrárias, Universidade Estadual de Londrina (UEL), Londrina, PR, Brasil. 5Departamento de Bioestatística, Instituto de Biociências, Universidade Estadual Paulista “Júlio de Mesquita Filho” (UNESP), 18618-693, Botucatu, SP, Brasil. ABSTRACT: Felis catus gammaherpesvirus 1 (FcaGHV1) may causes an asymptomatic infection that result in an efficient transmission and subsequently dissemination of the virus in feline population. This study used molecular detection by qPCR (quantitative PCR) based on DNA polymerase gene fragment amplification to evaluate the occurrence of FcaGHV1 and its correlation with other feline viral pathogens, such as Carnivore protoparvovirus 1 (CPPV-1), Felid alphaherpesvirus 1 (FeHV-1), and feline retroviruses such as feline immunodeficiency virus (FIV) and feline leukemia virus (FeLV). -
Carnivore Protoparvovirus 1 Nonstructural Protein 1 (NS1) Gene
Techne ® qPCR test Carnivore protoparvovirus 1 Nonstructural protein 1 (NS1) gene 150 tests For general laboratory and research use only Quantification of Carnivore protoparvovirus 1 genomes. 1 Advanced kit handbook HB10.03.07 Introduction to Carnivore protoparvovirus 1 Carnivore Protoparvovirus 1 is a genus in the virus family Parvoviridae, one of eight genera that contain viruses which infect vertebrate hosts and together make up the subfamily Parvovirinae. The conserved Nonstructural protein 1 (NS1) gene is the target for this genesig® detection kit. Carnivore protoparvovirus 1 is a small, linear, single-stranded DNA virus, with an icosahedral capsid that is non enveloped. The genome ranges from 4-6kb and as 2 open reading frames. 5’ ORF encodes 2 nonstructural proteins (NS1 & NS2) and the 3’ ORF encodes the capsid proteins. Five species are currently recognised, and most of these contain several different named viruses, virus strains, genotypes or serotypes. Due to the wide variety of types available, there are 4 species which prevalence is relatively high and are defined by the encoding for a particular replication protein, NS1 which is at least 85% identical to the protein encoded by other members of the species. Recognised species in genus Protoparvovirus include: Carnivore protoparvovirus 1 (includes canine arvovirus & feline parvovirus) Primate protoparvovirus 1 Rodent protoparvovirus Rodent protoparvovirus 2 (rat parvovirus 1) Ungulate parvovirus 1 (porcine parvovirus) Another virus in this group - Tusavirus 1 - has been reported from humans from Tunisia, Finland, Bhutan and Burkina Faso. Generalised symptoms are lethargy, vomiting, loss of appetite and diarrhoea which can cause dehydration. Carnivore protoparvovirus 1 in cats is known as Feline parvovirus (FPV) and can cause enteritis, panleukopnia and cerebellar ataxia in cats.Carnivore protoparvovirus 1 in dogs is called Canine parvovirus (CPV), can cause intestinal and lifelong cardiac disease in dogs. -
Large-Scale Analysis of Genome and Transcriptome Alterations in Multiple Tumors Unveils Novel Cancer-Relevant Splicing Networks
Downloaded from genome.cshlp.org on October 2, 2021 - Published by Cold Spring Harbor Laboratory Press Large-scale analysis of genome and transcriptome alterations in multiple tumors unveils novel cancer-relevant splicing networks Endre Sebestyén1,*, Babita Singh1,*, Belén Miñana1,2, Amadís Pagès1, Francesca Mateo3, Miguel Angel Pujana3, Juan Valcárcel1,2,4, Eduardo Eyras1,4,5 1Universitat Pompeu Fabra, Dr. Aiguader 88, E08003 Barcelona, Spain 2Centre for Genomic Regulation, Dr. Aiguader 88, E08003 Barcelona, Spain 3Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), E08908 L’Hospitalet del Llobregat, Spain. 4Catalan Institution for Research and Advanced Studies, Passeig Lluís Companys 23, E08010 Barcelona, Spain *Equal contribution 5Correspondence to: [email protected] Keywords: alternative splicing, RNA binding proteins, splicing networks, cancer 1 Downloaded from genome.cshlp.org on October 2, 2021 - Published by Cold Spring Harbor Laboratory Press Abstract Alternative splicing is regulated by multiple RNA-binding proteins and influences the expression of most eukaryotic genes. However, the role of this process in human disease, and particularly in cancer, is only starting to be unveiled. We systematically analyzed mutation, copy number and gene expression patterns of 1348 RNA-binding protein (RBP) genes in 11 solid tumor types, together with alternative splicing changes in these tumors and the enrichment of binding motifs in the alternatively spliced sequences. Our comprehensive study reveals widespread alterations in the expression of RBP genes, as well as novel mutations and copy number variations in association with multiple alternative splicing changes in cancer drivers and oncogenic pathways. Remarkably, the altered splicing patterns in several tumor types recapitulate those of undifferentiated cells. -
Identification of a Novel Parvovirus in Domestic Cats
Veterinary Microbiology 228 (2019) 246–251 Contents lists available at ScienceDirect Veterinary Microbiology journal homepage: www.elsevier.com/locate/vetmic Identification of a novel parvovirus in domestic cats T Georgia Diakoudia, Gianvito Lanavea, Paolo Capozzaa, Federica Di Profiob, Irene Melegarib, Barbara Di Martinob, Maria Grazia Pennisic, Gabriella Eliaa, Alessandra Cavallia, ⁎ Maria Tempestaa, Michele Cameroa, Canio Buonavogliaa, Krisztián Bányaid, Vito Martellaa, a Department of Veterinary Medicine, University of Bari, Valenzano, Italy b Faculty of Veterinary Medicine, University of Teramo, Teramo, Italy c Department of Veterinary Science, University of Messina, Italy d Institute for Veterinary Medical Research, Centre for Agricultural Research, Hungarian Academy of Sciences, Budapest, Hungary ARTICLE INFO ABSTRACT Keywords: A novel protoparvovirus species was identified in domestic cats. The virus was distantly related to the well- Parvovirus known feline (feline panleukopenia virus) and canine (canine parvovirus type 2) parvoviruses, sharing low Protoparvovirus nucleotide identities in the capsid protein 2 (less than 43%). The virus was genetically similar (100% at the Bufavirus nucleotide level) to a newly identified canine protoparvovirus, genetically related to human bufaviruses. The Cat feline bufavirus appeared as a common element of the feline virome, especially in juvenile cats, with an overall Respiratory infections prevalence of 9.2%. The virus was more common in respiratory samples (9.5%–12.2%) than in enteric samples of cats (2.2%). The role of bufaviruses in the etiology of feline respiratory disease complex, either as a primary or a secondary agents, should be defined. 1. Introduction described in cats (Lau et al., 2012; Ng et al., 2014; Zhang et al., 2014) (Table 1). -
2017 National Veterinary Scholars Symposium 18Th Annual August 4
2017 National Veterinary Scholars Symposium 18th Annual August – 4 5, 2017 Natcher Conference Center, Building 45 National Institutes of Health Bethesda, Maryland Center for Cancer Research National Cancer Institute with The Association of American Veterinary Medical Colleges https://www.cancer.gov/ Table of Contents 2017 National Veterinary Scholars Symposium Program Booklet Welcome .............................................................................................................................. 1 NIH Bethesda Campus Visitor Information and Maps .........................................................2 History of the National Institutes of Health ......................................................................... 4 Sponsors ............................................................................................................................... 5 Symposium Agenda .......................................................................................................6 Bios of Speakers ................................................................................................................. 12 Bios of Award Presenters and Recipients ........................................................................... 27 Training Opportunities at the NIH ...................................................................................... 34 Abstracts Listed Alphabetically .......................................................................................... 41 Symposium Participants by College of Veterinary Medicine -
Viruses Introduction
Chapter 1 Introduction to Viruses Viruses as a concept are just a little younger than bacteria - they were first described only in the 1890s - yet have probably co-existed with cellular life t h r o u g h n e a r l y t h e w h o l e o f evolutionary history on this planet. This chapter will give a brief account of the history of the discovery of viruses, concentrating on the technological developments that were necessary for the discovery events to happen. Chapter 1 Discovery of Viruses SUMMARY While people were aware of diseases of both humans and animals Viruses were discovered as an excluded now known to be caused by viruses many hundreds of years ago, entity rather than by being seen or the concept of a virus as a distinct entity dates back only to the cultured, due to the invention of efficient filters: the fact that cell-free extracts very late 1800s. Although the term had been used for many years from diseased plants and animals could previously to describe disease agents, the word “virus” comes from still cause disease led people to theorise that an unknown infectious a Latin word simply meaning “slimy fluid”. agent - a “filterable virus” - was responsible. Porcelain filters and the discovery of viruses The invention that allowed viruses to be discovered at all was the Chamberland- “Germ Proof Filter” Pasteur filter. This was developed in 1884 in Paris by Charles Chamberland, who from the Pasteur- worked with Louis Pasteur. It consisted of unglazed porcelain “candles”, with pore Chamberland Filter sizes of 0.1 – 1 micron (100 - 1000 nm), which could be used to completely remove all Co., Dayton, Ohio.